Examine the Psychosocial Impacts of COVID-19 Pandemic.

This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Indonesia, Iran, Iraq, Malaysia, Pakistan, Somaliland, and Turkiye). The data was obtained on standardised measures of wellbeing (WHO Well-Being Index), psychological distress (Kessler 10), post-traumatic stress (PTSD Checklist for DSM-5), post-traumatic growth (Posttraumatic Growth Inventory), and a novel pandemic-related stress (COVID Psychosocial Impacts Scale). Data was collected employing either a unilingual (in native language) or bilingual online survey (with English as a second language) from participants (N=2574) aged 18 and above using a non-probability convenient sampling. The findings enabled us to examine the psychosocial impacts of COVID-19, validate the translations of the CPIS and standardized measures; and determine the trajectory of study variables with pandemic exposure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psychosocial Impacts Behavior COVID-19 COVID-19 Pandemic Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Personal Satisfaction Pneumonia Pneumonia, Viral Psychological Well-Being RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitas Ahmad Dahlan, Yogyakarta, Indonesia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged 18 and above
Currently residing in the country of interest.
Additional inclusion criterion applies to bilingual studies; which is having English as a second language.

Exclusion criteria

Aged below 18 years.
Not residing in the country of interest.
Additional exclusion criterion applies to bilingual studies; which is not having English as a second language.

Treatment and study plan

Primary outcomes

Examining the psychosocial impacts of the COVID-19 pandemic.

Time frame: Data was collected in a short-time window on each site. The time of data collection varies across site and was collected from Dec 2021 to Sep 2023.

To explore the psychosocial impacts of the COVID-19 pandemic on self-report measures of wellbeing (WHO-5), psychological distress (K10), post-traumatic stress (PCL-5), post-traumatic growth (PTGI), and pandemic-related stress (CPIS) in seven LMICs. The data will be collected employing a unilingual (Indonesia, Somaliland, Turkey) or bilingual (Iran, Iraq, Malaysia, Pakistan) survey. With-in-subjects and between-subjects designs together with exploratory regression analyses will be employed to characterize this outcome.

Other outcomes

Analyzing the psychometric properties of the translations of the newly developed CPIS and other standardized measures.

Time frame: The time of data collection varies across site and was collected from Dec 2021 to Sep 2023.

The findings will give psychometric information on the translations and suitability of use of the newly developed CPIS and other standardized questionnaires (K10, WHO-5, PCL-5, PTGI) in seven LMICs. The metric used to characterize this outcome involves reliability (internal consistency) and validity (construct) analyses.

Sponsors and collaborators

Lead sponsor

University of Otago

Other

Collaborators

Al-Mustansiriyah University
Gadjah Mada University
Hasan Kalyoncu University
Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq
International Islamic University, Islamabad
Universitas Ahmad Dahlan
University of Malaya
University of Social Welfare and Rehabilitation Science
University of Washington

Registry information

Official study title

An International Study Examining the Psychosocial Impacts of COVID-19 Pandemic.

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Sep 22, 2021
Registry last updated: Dec 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed